Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28.32 | 1 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Heron Therapeutics, Inc. | $28.32 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.32 | 1 | Heron Therapeutics, Inc. ($28.32) |
All Payment Transactions
1 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | Heron Therapeutics, Inc. | APONVIE (Drug), ZYNRELEF | Food and Beverage | Cash or cash equivalent | $28.32 | General |
| Category: NAUSEAVOMITING | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 9 | 192 | 199 | $29,114 | $6,706 |
| 2021 | 30 | 1,378 | 1,718 | $200,739 | $69,597 |
| 2020 | 28 | 1,326 | 1,674 | $186,475 | $59,318 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $4,940 | $2,141 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 51 | $14,982 | $2,022 | 13.5% |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | Office | 2022 | 12 | 12 | $2,040 | $900.00 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 22 | $4,553 | $552.66 | 12.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 19 | 19 | $712.50 | $319.20 | 44.8% |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | Office | 2022 | 12 | 12 | $600.00 | $300.00 | 50.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 19 | 19 | $779.00 | $254.41 | 32.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 35 | 37 | $268.25 | $111.00 | 41.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 11 | $239.25 | $106.81 | 44.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 165 | 309 | $87,370 | $26,102 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 98 | 98 | $30,074 | $13,206 | 43.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 124 | 154 | $30,146 | $8,778 | 29.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 20 | 20 | $9,025 | $3,414 | 37.8% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 17 | 17 | $6,401 | $2,326 | 36.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 132 | 144 | $5,904 | $1,928 | 32.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 95 | 106 | $3,975 | $1,781 | 44.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 14 | 14 | $3,678 | $1,751 | 47.6% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 24 | 24 | $3,285 | $1,562 | 47.5% |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | Office | 2021 | 13 | 13 | $2,210 | $975.00 | 44.1% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 15 | 15 | $2,231 | $842.70 | 37.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 64 | 85 | $1,849 | $815.64 | 44.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 59 | 71 | $1,580 | $749.76 | 47.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2021 | 38 | 38 | $1,568 | $714.47 | 45.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 168 | 241 | $1,747 | $714.00 | 40.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2021 | 34 | 36 | $1,215 | $542.88 | 44.7% |
About Dr. John Beard, MD
Dr. John Beard, MD is a Sports Medicine healthcare provider based in Mukilteo, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225118201.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Beard, MD has received a total of $28.32 in payments from pharmaceutical and medical device companies, with $28.32 received in 2024. These payments were reported across 1 transactions from 1 company. The most common payment nature is "Food and Beverage" ($28.32).
As a Medicare-enrolled provider, Beard has provided services to 2,896 Medicare beneficiaries, totaling 3,591 services with total Medicare billing of $135,622. Data is available for 3 years (2020–2022), covering 67 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine
- Location Mukilteo, WA
- Active Since 10/16/2006
- Last Updated 03/15/2017
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1225118201
Products in Payments
- APONVIE (Drug) $28.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.